The Impacts of STI Testing Innovation: Elitza Theel, Ph.D.


Answers From the Lab

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, for a conversation about innovation in testing for sexually transmitted infections (STI). Topics include:

  • The advantages and challenges of new types of specimen collection and testing methods, including over-the-counter, at-home, and point-of-care options.
  • Implications home testing has for clinicians and public health.
  • Barriers to making more at-home collection and over-the-counter testing products for STI testing.
  • The growing need for tests to detect resistance markers as antimicrobial resistance increases.

Podcast episode

Note: Podcasts will not playback on Internet Explorer. Please use an alternative web browser, or listen from your mobile device on a preferred listening app.

Podcast episode in video format

Answers from the Lab is a Mayo Clinic Laboratories curated podcast sharing knowledge and advancements regarding the state of testing, laboratory science, and the people who make it all happen behind the scenes. 

Information in this post was accurate at the time of its posting.

Jessie Fenske

Jessie Fenske is a senior marketing specialist at Mayo Clinic Laboratories. She joined Mayo Clinic in 2010 and enjoys partnering with patients and employees to share their stories of innovation, persistence and hope.